Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

63.40p
   
  • Change Today:
      0.60p
  • 52 Week High: 102.00
  • 52 Week Low: 58.00
  • Currency: UK Pounds
  • Shares Issued: 515.13m
  • Volume: 469,929
  • Market Cap: 326.59m
  • RiskGrade: 202
  • Beta: 0.73

Alliance Pharma Overview

Alliance Pharma is in the pharma and biotech sector and is currently trading at 63.40p per share. In the last year Alliance Pharma's share price has ranged from 58.00p to 102.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (16-11-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 2.1% 2.2%
Div Cover 4.0 3.0
Op Mrgn 29.2% 23.2%
ROCE 85.8%  
Latest F'cast
P/E 11.9 14.0
PEG 0.3 n/a
Pr/Revenue 3.2 2.7
Pr/Book 1.6  
Latest F'cast
Revenue 6.0% 18.4%
PBT 27.7% -0.0%
EPS 38.7% -15.1%
DPS 10.0% 11.7%

Alliance Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 45.28 12.01 3.82p 10.6 1.8 +6% 0.91p 2.2%
31-Dec-14 43.54 10.16 3.36p 10.9 n/a -12% 1.00p 2.7%
31-Dec-15 48.34 15.18 3.52p 12.2 2.4 +5% 1.10p 2.6%
31-Dec-16 97.49 22.22 3.85p 12.3 1.4 +9% 1.21p 2.6%
31-Dec-17 103.31 28.37 5.34p 12.6 0.3 +39% 1.33p 2.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 122.30 28.37 4.53p 14.0 n/a -15% 1.49p 2.2%
31-Dec-19 139.27 33.27 5.03p 12.6 1.1 +11% 1.60p 2.4%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Director Share Dealing 12-Nov-2018 15:51 RNS
Grant of Options to Directors 05-Oct-2018 10:25 RNS
Xonvea launch in the UK 02-Oct-2018 07:00 RNS

Latest Alliance Pharma Director Deals

Traded Action Notifier PriceAmountValue
09-Nov-18 Sell John Dawson 70.10p 1,100,000 771,099.97

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 63.40p
Change Today 0.60p
% Change 0.96 %
52 Week High 102.00
52 Week Low 58.00
Volume 469,929
Shares Issued 515.13m
Market Cap 326.59m
Beta 0.73
RiskGrade 202

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.13% below the market average41.13% below the market average41.13% below the market average41.13% below the market average41.13% below the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average
Price Trend
34.57% above the market average34.57% above the market average34.57% above the market average34.57% above the market average34.57% above the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Income
24.59% below the market average24.59% below the market average24.59% below the market average24.59% below the market average24.59% below the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average
Growth
81.10% above the market average81.10% above the market average81.10% above the market average81.10% above the market average81.10% above the market average
94.74% above the sector average94.74% above the sector average94.74% above the sector average94.74% above the sector average94.74% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 20-Dec-18 14-Jun-18
Paid 10-Jan-19 11-Jul-18
Amount 0.49p 0.89p

Trades for 16-Nov-2018

Time Volume / Share Price
16:51 8,000 @ 62.00p
16:35 87,766 @ 63.40p
16:29 1,163 @ 63.60p
16:29 2,439 @ 63.20p
16:29 893 @ 63.20p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page